Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Gilead Sciences Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Sofosbuvir / Velpatasvir

Brand Name : EPCLUSA

Patent Number : 2682230

Filing Date : 2008-03-26

Strength per Unit : 400 mg / 100 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2028-03-26

Date Granted : 2014-04-22

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Sofosbuvir / Velpatasvir

Brand Name : EPCLUSA

Patent Number : 2815082

Filing Date : 2012-11-16

Strength per Unit : 400 mg / 100 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2032-11-16

Date Granted : 2015-07-07

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Sofosbuvir / Velpatasvir

Brand Name : EPCLUSA

Patent Number : 2794669

Filing Date : 2011-03-31

Strength per Unit : 400 mg / 100 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2031-03-31

Date Granted : 2016-10-11

blank